Skip to main content

Advertisement

SpringerLink
Log in

Management of Chronic Cluster Headache

  • Headache
  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Primary cluster headache (CH) is an excruciatingly severe pain condition. Several pharmacologic agents are available to treat chronic CH, but few double-blind, randomized clinical trials have been conducted on these agents in recent years, and the quality of the evidence supporting their use is often low, particularly for preventive agents. We recommend sumatriptan or oxygen to abort ongoing headaches; the evidence available to support their use is good (Class I). Ergotamine also appears to be an effective abortive agent, on the basis of experience rather than trials. We consider verapamil and lithium to be first-line preventives for chronic CH, although the trial evidence is at best Class II. Steroids are clearly the most effective and quick-acting preventive agents for chronic CH, but long-term steroid use carries a risk of several severe adverse effects. We therefore recommend steroids only if verapamil, lithium, and other preventive agents are ineffective. In rare cases, patients experience multiple daily cluster headaches for years and are also refractory to all medications. These patients almost always develop severe adverse effects from chronic steroid use. Such patients should be considered for neurostimulation. Occipital nerve stimulation is the newest and least invasive neurostimulation technique and should be tried first; the evidence supporting its use is encouraging. Hypothalamic stimulation is more invasive and can be performed only in specialist neurosurgical centers. Published experience suggests that about 60% of patients with chronic CH obtain long-term benefit with hypothalamic stimulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance••Of major importance

  1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004, 24 (Supplement 1): 1-160.

  2. Kudrow L: Cluster Headache, Mechanism and Management. New York: Oxford University Press; 1980.

    Google Scholar 

  3. Sjaastad O 1992 Cluster Headache Syndrome. WB. Saunders Company Ltd. Volume 23: Major Problems in Neurology. London-Philadelphia-Toronto.

  4. Sjaastad O, Bakketeig LS: Cluster headache prevalence. Vågå study of headache epidemiology. Cephalalgia 2003, 23(7):528–533.

    Article  CAS  PubMed  Google Scholar 

  5. Russell MB: Epidemiology and genetics of cluster headache. Lancet Neurol 2004, 3(5):279–283.

    Article  PubMed  Google Scholar 

  6. Manzoni GC, Micieli G, Granella F, et al.: Cluster headache-course over ten years in 189 patients. Cephalalgia 1991, 11:169–174.

    Article  CAS  PubMed  Google Scholar 

  7. May A, Leone M, Áfra J, et al.: EFNS guideline on the treatment of cluster headache and other trigemino-autonomic cephalgias. Eur J Neurol 2006, 13:1066–1077.

    Article  CAS  PubMed  Google Scholar 

  8. May A: Cluster headache: pathogenesis, diagnosis, and management. Lancet 2005, 366(9488):843–855.

    Article  PubMed  Google Scholar 

  9. The Sumatriptan Cluster Headache Study Group: Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991, 325(5):322–326.

    Article  Google Scholar 

  10. Ekbom K, Monstad I, Prusinski A, et al.: Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurol Scand 1993, 88(1):63–69.

    Article  CAS  PubMed  Google Scholar 

  11. Van Vliet JA, Bahra A, Martin V, et al.: Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology 2003, 60(4):630–633.

    Article  PubMed  Google Scholar 

  12. Bahra A, Gawel MJ, Hardebo JE, et al.: Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 2000, 54(9):1832–1839.

    CAS  PubMed  Google Scholar 

  13. Rapoport A, Mathew NT, Silberstein SD, et al.: Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology 2007, 28(9):821–826.

    Article  Google Scholar 

  14. Göbel H, Lindner V, Heinze A, Ribbat M, Deuschl G: Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology 1998, 51(3):908–911.

    PubMed  Google Scholar 

  15. Plosker GL, McTavish D: Sumatriptan: a reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1994, 47(4):622–651.

    Article  CAS  PubMed  Google Scholar 

  16. Anghileri E, Toso V, Perini F: Acute myocardial infarction after sumatriptan administration for cluster headache. Neurol Sci 2006, 26:456–459.

    Article  CAS  PubMed  Google Scholar 

  17. Bennett MH, French C, Schnabel A, Wasiak J, Kranke P: Normobaric and hyperbaric oxygen therapy for migraine and cluster headache. Cochrane Database Syst Rev 2008, 16(3):CD005219.

    Google Scholar 

  18. Horton B, Ryan R, Reynolds J: Clinical observations of the use of E.C. 110, a new agent for the treatment of headache. Mayo Clin Proc 1948, 23:104–108.

    Google Scholar 

  19. Andersson PG, Jespersen LT: Dihydroergotamine nasal spray in the treatment of attacks of cluster headache. A double-blind trial versus placebo. Cephalalgia 1986, 6(1):51–54.

    Article  CAS  PubMed  Google Scholar 

  20. Magnoux E, Zlotnik G: Outpatient intravenous dihydroergotamine for refractory cluster headache. Headache 2004, 44(3):249–255.

    Article  CAS  PubMed  Google Scholar 

  21. Matharu MS, Levy MJ, Meeran K, Goadsby PJ: Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol 2004, 56(4):488–494.

    Article  CAS  PubMed  Google Scholar 

  22. Costa A, Pucci E, Antonaci F, et al.: The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia 2000, 20(2):85–91.

    Article  CAS  PubMed  Google Scholar 

  23. Francis GJ, Becker WJ, Pringsheim TM. Acute and preventive pharmacologic treatment of cluster headache. Neurology 2010, 75(5):463-73.

    Article  PubMed  Google Scholar 

  24. Saper JR, Klapper J, Mathew NT, et al.: For the Intranasal Civamide Study Group: intranasal civamide for the treatment of episodic cluster headaches. Arch Neurol 2002, 59:990–994.

    Article  PubMed  Google Scholar 

  25. Edlund W, Gronseth G, So Y, Franklin G: Clinical Practice Guideline Process Manual. St. Paul: American Academy of Neurology; 2004:1–57.

    Google Scholar 

  26. Gabai IJ, Spierings EL: Prophylactic treatment of cluster headache with verapamil. Headache 1989, 29:167–168.

    Article  CAS  PubMed  Google Scholar 

  27. Leone M, D’Amico D, Frediani F, et al.: Verapamil in the prophylaxis of episodic cluster headache: a double-blind study vs. placebo. Neurology 2000, 54:1382–1385.

    CAS  PubMed  Google Scholar 

  28. Cohen AS, Matharu MS, Goadsby PJ: Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology 2007, 69:668–675.

    Article  CAS  PubMed  Google Scholar 

  29. Ekbom K: Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache 1981, 21:132–139.

    Article  CAS  PubMed  Google Scholar 

  30. Bussone G, Leone M, Peccarisi C, et al.: Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990, 30:411–417.

    Article  CAS  PubMed  Google Scholar 

  31. Curran DA, Hinterberger H, Lance J: Methysergide. Res Clin Stud Headache 1967, 1:74–122.

    CAS  Google Scholar 

  32. Ekbom K: Ergotamine tartrate orally in Horton's histaminic cephalalgia (also called Harris's ciliary neuralgia). Acta Psychiatr Scand 1947, 46:106.

    Google Scholar 

  33. Mather PJ, Silberstein SD, Schulman EA, Hopkins MM: The treatment of cluster headache with repetitive intravenous dihydroergotamine. Headache 1991, 31:525–532.

    Article  CAS  PubMed  Google Scholar 

  34. Leone M, Dodick D, Rigamonti A, et al.: Topiramate in cluster headache prophylaxis: an open trial. Cephalalgia 2003, 23:1001–1002.

    Article  CAS  PubMed  Google Scholar 

  35. Pascual J, Láinez MJ, Dodick D, Hering-Hanit R: Antiepileptic drugs for the treatment of chronic and episodic cluster headache: a review. Headache 2007, 47(1):81–89.

    Article  PubMed  Google Scholar 

  36. Ekbom K: Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105. Acta Neurol Scand 1969, 45:601–610.

    Article  CAS  PubMed  Google Scholar 

  37. Hering R, Kuritzky A: Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia 1989, 9:195–198.

    Article  CAS  PubMed  Google Scholar 

  38. Schuh-Hofer S, Israel H, Neeb L, et al.: The use of gabapentin in chronic cluster headache patients refractory to first-line therapy. Eur J Neurol 2007, 14(6):694–696.

    Article  CAS  PubMed  Google Scholar 

  39. Leone M, D’Amico D, Moschiano F, et al.: Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 1996, 16:494–496.

    Article  CAS  PubMed  Google Scholar 

  40. Couch JR, Ziegler DK: Prednisone therapy for cluster headache. Headache 1978, 18:219–221.

    Article  PubMed  Google Scholar 

  41. May A, Bahra A, Büchel C, et al.: Hypothalamic activation in cluster headache attacks. Lancet 1998, 352:275–278.

    Article  CAS  PubMed  Google Scholar 

  42. May A, Ashburner J, Buchel C, et al.: Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 1999, 5:836–838.

    Article  CAS  PubMed  Google Scholar 

  43. Leone M, Franzini A, Bussone G: Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med 2001, 345(19):1428–1429.

    Article  CAS  PubMed  Google Scholar 

  44. Leone M, Franzini A, Broggi G, et al.: Long-term follow up of bilateral hypothalamic stimulation for intractable cluster headache. Brain 2004, 127:2259–2264.

    Article  CAS  PubMed  Google Scholar 

  45. Leone M, Franzini A, Broggi G, Bussone G: Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology 2006, 67(1):150–152.

    Article  PubMed  Google Scholar 

  46. Leone M, Proietti Cecchini A, Franzini A, et al. Lessons from 8 years’ experience of hypothalamic stimulation in cluster headache. Cephalalgia 2008, 28:789–797.

    Google Scholar 

  47. Leone M, Proietti A, Mea E et al. Therapeutic neurostimulation in chronic headaches: problems of patient selection. Neurol Sci 2008; 29: S59–S61.

    Article  PubMed  Google Scholar 

  48. Burns B, Watkins L, Goadsby PJ: Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet 2007, 369(9567):1099–1106.

    Article  PubMed  Google Scholar 

  49. Magis D, Allena M, Bolla M, et al.: Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol 2007, 6:314–321.

    Article  PubMed  Google Scholar 

  50. Schwedt TJ, Dodick DW, Hentz J, et al.: Occipital nerve stimulation for chronic headache—long-term safety and efficacy. Cephalalgia 2007, 27:153–157.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Pain Neuromodulation Unit, Department of Neurology, Headache Center, Carlo Besta Neurological Institute Foundation, Via Celoria 11, 20133, Milano, Italy

    Massimo Leone MD, Alberto Proietti Cecchini MD, Eliana Mea, Giovanni Broggi & Gennaro Bussone

  2. Department of Neurosurgery, Carlo Besta Neurological Institute Foundation, Via Celoria 11, 20133, Milano, Italy

    Angelo Franzini MD

Authors
  1. Massimo Leone MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angelo Franzini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alberto Proietti Cecchini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eliana Mea
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giovanni Broggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gennaro Bussone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Leone MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leone, M., Franzini, A., Proietti Cecchini, A. et al. Management of Chronic Cluster Headache. Curr Treat Options Neurol 13, 56–70 (2011). https://doi.org/10.1007/s11940-010-0106-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-010-0106-5

Keywords

Search

Navigation